India Business Excellence Fund-Iv
Case brief
What is this about?
The Competition Commission of India approved a proposed combination where India Business Excellence Fund IV acquired approximately 2.85% stake in Niva Bupa Health Insurance. The Commission found the matter satisfied the safe harbour threshold and did not likely cause an appreciable adverse effect on competition in any relevant market.
What did the court decide?
The proposed combination is approved under Section 31(1) of the Competition Act, 2002, as it is not likely to cause an appreciable adverse effect on competition in India.